Chronic Kidney Disease and Antiretroviral Therapy in HIV-Positive Individuals: Recent Developments
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Chronic Kidney Disease and Antiretroviral Therapy in HIV-Positive Individuals: Recent Developments
Authors
Keywords
HIV, HAART, cART, Kidney, Renal, Tenofovir, Antiretroviral therapy, Dual therapy, GFR, Proteinuria
Journal
Current HIV/AIDS Reports
Volume 13, Issue 3, Pages 149-157
Publisher
Springer Nature
Online
2016-04-30
DOI
10.1007/s11904-016-0315-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Higher tenofovir exposure is associated with longitudinal declines in kidney function in women living with HIV
- (2016) Sanjiv M. Baxi et al. AIDS
- Tenofovir alafenamide: A novel prodrug of tenofovir for the treatment of Human Immunodeficiency Virus
- (2016) Adrian S. Ray et al. ANTIVIRAL RESEARCH
- Elevations in Serum Creatinine With Tenofovir-Based HIV Pre-Exposure Prophylaxis
- (2016) Rabi Yacoub et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Reversibility of Glomerular Renal Function Decline in HIV-Uninfected Men and Women Discontinuing Emtricitabine-Tenofovir Disoproxil Fumarate Pre-Exposure Prophylaxis
- (2016) Kenneth K. Mugwanya et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in antiretroviral regimens for virologically suppressed adults with HIV-1 infection: a randomised, active-controlled, multicentre, open-label, phase 3, non-inferiority study
- (2016) Anthony Mills et al. LANCET INFECTIOUS DISEASES
- Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: a prospective international cohort study
- (2016) Amanda Mocroft et al. Lancet HIV
- Dual Therapy Treatment Strategies for the Management of Patients Infected with HIV: A Systematic Review of Current Evidence in ARV-Naive or ARV-Experienced, Virologically Suppressed Patients
- (2016) Jean-Guy Baril et al. PLoS One
- Nonalbumin proteinuria predominates in biopsy-proven tenofovir nephrotoxicity
- (2015) Meghan E. Sise et al. AIDS
- Kidney disease in antiretroviral-naïve HIV-positive adults with high CD4 counts: prevalence and predictors of kidney disease at enrolment in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial
- (2015) AC Achhra et al. HIV MEDICINE
- Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials
- (2015) Paul E Sax et al. LANCET
- Dual treatment with lopinavir–ritonavir plus lamivudine versus triple treatment with lopinavir–ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): a randomised, open-label, non-inferiority trial
- (2015) José R Arribas et al. LANCET INFECTIOUS DISEASES
- Dual treatment with atazanavir–ritonavir plus lamivudine versus triple treatment with atazanavir–ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial
- (2015) José A Perez-Molina et al. LANCET INFECTIOUS DISEASES
- An updated prediction model of the global risk of cardiovascular disease in HIV-positive persons: The Data-collection on Adverse Effects of Anti-HIV Drugs (D:A:D) study
- (2015) Nina Friis-Møller et al. European Journal of Preventive Cardiology
- Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study
- (2015) Amanda Mocroft et al. PLOS MEDICINE
- Changes in Glomerular Kidney Function Among HIV-1–Uninfected Men and Women Receiving Emtricitabine–Tenofovir Disoproxil Fumarate Preexposure Prophylaxis
- (2015) Kenneth K. Mugwanya et al. JAMA Internal Medicine
- Time trends for risk of severe age-related diseases in individuals with and without HIV infection in Denmark: a nationwide population-based cohort study
- (2015) Line D Rasmussen et al. Lancet HIV
- Long-term exposure to tenofovir continuously decrease renal function in HIV-1-infected patients with low body weight
- (2014) Takeshi Nishijima et al. AIDS
- Changes in renal function associated with oral emtricitabine/tenofovir disoproxil fumarate use for HIV pre-exposure prophylaxis
- (2014) Marc M. Solomon et al. AIDS
- Cross-sectional Comparison of the Prevalence of Age-Associated Comorbidities and Their Risk Factors Between HIV-Infected and Uninfected Individuals: The AGEhIV Cohort Study
- (2014) J. Schouten et al. CLINICAL INFECTIOUS DISEASES
- Clinical Practice Guideline for the Management of Chronic Kidney Disease in Patients Infected With HIV: 2014 Update by the HIV Medicine Association of the Infectious Diseases Society of America
- (2014) Gregory M. Lucas et al. CLINICAL INFECTIOUS DISEASES
- Dolutegravir: Clinical and Laboratory Safety in Integrase Inhibitor–Naive Patients
- (2014) L. Curtis et al. HIV CLINICAL TRIALS
- Incomplete Reversibility of Estimated Glomerular Filtration Rate Decline Following Tenofovir Disoproxil Fumarate Exposure
- (2014) Sophie Jose et al. JOURNAL OF INFECTIOUS DISEASES
- Ritonavir-boosted darunavir combined with raltegravir or tenofovir–emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001/ANRS143 randomised non-inferiority trial
- (2014) François Raffi et al. LANCET
- Moving Away from Ritonavir, Abacavir, Tenofovir, and Efavirenz (RATE) - Agents That Concern Prescribers and Patients: A Feasibility Study and Call for a Trial
- (2014) Amit C. Achhra et al. PLoS One
- Renal impairment in HIV-infected patients initiating tenofovir-containing antiretroviral therapy regimens in a Primary Healthcare Setting in South Africa
- (2014) Monika Kamkuemah et al. TROPICAL MEDICINE & INTERNATIONAL HEALTH
- Predictors of advanced chronic kidney disease and end-stage renal disease in HIV-positive persons
- (2013) Lene Ryom et al. AIDS
- Association Between Antiretroviral Exposure and Renal Impairment Among HIV-Positive Persons With Normal Baseline Renal Function: the D:A:D Studya
- (2013) L. Ryom et al. JOURNAL OF INFECTIOUS DISEASES
- The validity of the modification of diet in renal disease formula in HIV-infected patients: a systematic review
- (2013) Willemijn L. Eppenga et al. JOURNAL OF NEPHROLOGY
- Tenofovir Effect on the Kidneys of HIV-Infected Patients: A Double-Edged Sword?
- (2013) J. Tourret et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Antiretroviral regimens sparing agents from the nucleoside(tide) reverse transcriptase inhibitor class: a review of the recent literature
- (2013) Amit C Achhra et al. AIDS Research and Therapy
- Risk Factors for ESRD in HIV-Infected Individuals: Traditional and HIV-Related Factors
- (2011) Vasantha Jotwani et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Comparison of CKD-EPI and MDRD to estimate baseline renal function in HIV-positive patients
- (2011) Fowzia Ibrahim et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients
- (2010) Amanda Mocroft et al. AIDS
- Cost‐Effectiveness of Tenofovir as First‐Line Antiretroviral Therapy in India
- (2010) Melissa A. Bender et al. CLINICAL INFECTIOUS DISEASES
- Systematic Review and Meta‐analysis: Renal Safety of Tenofovir Disoproxil Fumarate in HIV‐Infected Patients
- (2010) Ryan D. Cooper et al. CLINICAL INFECTIOUS DISEASES
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started